Stockreport

Anebulo Pharmaceuticals Announces First Patients Dosed in Phase 1 Single Ascending Dose Study of Intravenous Selonabant, under Development for Acute Cannabis-Induced Toxicity [Yahoo! Finan...

Anebulo Pharmaceuticals, Inc.  (ANEB) 
PDF company developing novel solutions for people suffering from acute cannabinoid-induced toxicities (the "Company" or "Anebulo"), today announces the first subjects dosed [Read more]